Literature DB >> 23621216

Expression and significance of twist and E-cadherin in ovarian cancer tissues.

Wen-Shuang Wang1, Shou-Li Yu, Xing-Sheng Yang, Shu-De Chang, Jian-Qing Hou.   

Abstract

OBJECTIVE: To investigate the expression of Twist and E-cadherin in ovarian cancer tissues as well as the role of epithelial-mesenchymal transformation (EMT) in ovarian cancer metastasis.
METHOD: The expressions of Twist and E-cadherin in 54 cases of ovarian cancer and paracancerous tissues were detected by Western blottin g and reverse transcriptase polymerase chain reaction. We used RNA interference to silence Twist expression in human ovarian cancer cell line, and detected E-cadherin expression using Western blotting.
RESULTS: There was an increase in the relative abundance of Twist proteins and a decrease in E-cadherin in ovarian cancer compared with normal ovary tissues (P < 0.05). The expression levels of Twist and E-cadherin mRNA were 1.49 ± 0.53 and 0.82 ± 0.24 in ovarian cancer, and 1.14 ± 0.38 and 1.08 ± 0.19 in paracancerous tissues, respectively. The difference between the indicators in ovarian cancer and in paracancerous tissues was statistically significant (P < 0.05). When the Twist expression was silenced in an ovarian cancer cell line, the expression of the E-cadherin protein increased (P<0.05).
CONCLUSION: The expression of Twist is upregulated, whereas that of E-cadherin is downregulated in ovarian cancer. EMT, mediated by Twist, may be correlated with ovarian cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23621216     DOI: 10.7314/apjcp.2013.14.2.669

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.

Authors:  Ling Wei; Ju-Jie Sun; Yong-Chun Cui; Shu-Li Jiang; Xing-Wu Wang; Li-Yan Lv; Li Xie; Xian-Rang Song
Journal:  Tumour Biol       Date:  2016-01-27

2.  PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.

Authors:  Sreedevi Avasarala; Michelle Van Scoyk; Manoj Kumar Karuppusamy Rathinam; Sereke Zerayesus; Xiangmin Zhao; Wei Zhang; Melissa R Pergande; Jeffrey A Borgia; James DeGregori; J David Port; Robert A Winn; Rama Kamesh Bikkavilli
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

Review 3.  TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis.

Authors:  Sudhakar V Nuti; Gil Mor; Peiyao Li; Gang Yin
Journal:  Oncotarget       Date:  2014-09-15

Review 4.  Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.

Authors:  Junli Deng; Li Wang; Hongmin Chen; Jingli Hao; Jie Ni; Lei Chang; Wei Duan; Peter Graham; Yong Li
Journal:  Oncotarget       Date:  2016-08-23

5.  Claudin-4 Immunoexpression in Urothelial Carcinomas.

Authors:  Andrei Ştefan SĂndulescu; Alex Emilian Stepan; Claudiu MĂrgĂritescu; Anne Marie Badiu; Marius Matei; Cristiana Eugenia Simionescu
Journal:  Curr Health Sci J       Date:  2020-12-31

6.  MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.

Authors:  Xiaochun Sun; Manhua Cui; Aichen Zhang; Lingling Tong; Kun Wang; Kai Li; Xue Wang; Ziqian Sun; Hongye Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.